Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239094 · ClinicalTrials.gov registry record · NA
Biosignatures of Latuda for Bipolar Depression
A NA study of Bipolar Depression, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02239094 is a NA study of Bipolar Depression that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 20 participants, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02239094, a NA study of Bipolar Depression, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The study proposes to conduct a pilot study of biological predictors of lurasidone response in bipolar depression.
Conditions Studied
Interventions
- DRUG Lurasidone (Latuda)
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02239094
The ClinicalTrials.gov registry entry for NCT02239094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (91% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Lurasidone (Latuda) is the first listed.
NCT02239094 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02239094 about?
NCT02239094 is a clinical study titled "Biosignatures of Latuda for Bipolar Depression". The study proposes to conduct a pilot study of biological predictors of lurasidone response in bipolar depression.
What is the current status of trial NCT02239094?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-01. Estimated completion is 2016-09.
What conditions does trial NCT02239094 study?
This clinical trial studies the following conditions: Bipolar Depression.
What interventions are being tested in trial NCT02239094?
The interventions under investigation include: Lurasidone (Latuda) (DRUG).
Who is sponsoring clinical trial NCT02239094?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02239094 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketogenic Intervention for Bipolar Depression
RECRUITING · NA
-
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
RECRUITING · NA
-
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
ACTIVE NOT RECRUITING · NA
-
Focused Ultrasound Amygdala Neuromodulation
ACTIVE NOT RECRUITING · NA
-
Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device
COMPLETED · NA
-
Vitamin D Supplementation for Bipolar Depression
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.